PERSEUS HOLDINGS
Perseus Holdings is an immuno-oncology company that is focused on the development and commercialization of immune-mediated technologies for the treatment of cancer. The company holds executive licenses for the tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine, and the tumor lysate, particle only (TLPO) vaccine – both personalized therapeutic cancer vaccines designed to attack cancer cells by igniting innate and adaptive immune responses which increase a patient's own production of T cells to fight their specific cancer. Perseus Holdings was founded in 2014 and is based in Austin, Texas.
PERSEUS HOLDINGS
Industry:
Biotechnology Commercial Health Care Wellness
Founded:
2012-01-01
Address:
Austin, Texas, United States
Country:
United States
Website Url:
http://www.perseusholdingsusa.com
Total Employee:
11+
Status:
Active
Total Funding:
2.39 M USD
Similar Organizations
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Imvax
Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Current Employees Featured
Official Site Inspections
http://www.perseusholdingsusa.com Semrush global rank: 5.18 M Semrush visits lastest month: 1.56 K
- Host name: 184.106.55.72
- IP address: 184.106.55.72
- Location: Lansing United States
- Latitude: 42.7348
- Longitude: -84.6245
- Metro Code: 551
- Timezone: America/Detroit
- Postal: 48917
